DORZOLAMIDE/TIMOLOL VIATRIS 20 mg/ml + 5 mg/ml, eye drop solution bottle, 5 ml
Active ingredients: Dorzolamide hydrochloride, Dorzolamide, Timolol maleate, TIMOLOL BASE
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 5 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DORZOLAMIDE/TIMOLOL VIATRIS 20 mg/ml + 5 mg/ml, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène de 5 ml avec compte-gouttes polyéthylène basse densité (PEBD)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 May 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68569129CIP74196069CIP133400941960697Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | — | SA |
| TIMOLOL BASEcollyre | 5 mg · 1 ml | FT |
| DORZOLAMIDE BASEcollyre | 20 mg · 1 ml | FT |
| CHLORHYDRATE DE DORZOLAMIDEcollyre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.